Skip to main content
. 2016 Jul 15;129(14):2804–2816. doi: 10.1242/jcs.188045

Fig. 1.

Fig. 1.

SNX9 expression in lung and breast cancers. (A) Example of immunohistochemical (IHC) staining of SNX9 in two human NSCLC tumors. Bar chart represents quantification (H-score, see Materials and Methods) of SNX9 staining in stage I (n=97), stage II (n=36) and stage III (n=59) NSCLC. (B) Representative image of IHC staining of SNX9 in human normal breast tissue versus in situ ductal breast carcinoma. Bar chart represents quantification of SNX9 staining in normal versus patient tumor tissues. n=10 for each condition. Scale bars: 200 µm. Results are presented as mean±s.e.m. Statistical significance was evaluated using one-way ANOVA. ****P<0.0001.